These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23504005)

  • 1. Nucleotides in the eye: focus on functional aspects and therapeutic perspectives.
    Guzman-Aranguez A; Santano C; Martin-Gil A; Fonseca B; Pintor J
    J Pharmacol Exp Ther; 2013 Jun; 345(3):331-41. PubMed ID: 23504005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dinucleoside polyphosphates in the eye: from physiology to therapeutics.
    Guzmán-Aranguez A; Crooke A; Peral A; Hoyle CH; Pintor J
    Prog Retin Eye Res; 2007 Nov; 26(6):674-87. PubMed ID: 17931952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleotides in ocular secretions: their role in ocular physiology.
    Crooke A; Guzmán-Aranguez A; Peral A; Abdurrahman MK; Pintor J
    Pharmacol Ther; 2008 Jul; 119(1):55-73. PubMed ID: 18562011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purines in the eye: recent evidence for the physiological and pathological role of purines in the RPE, retinal neurons, astrocytes, Müller cells, lens, trabecular meshwork, cornea and lacrimal gland.
    Sanderson J; Dartt DA; Trinkaus-Randall V; Pintor J; Civan MM; Delamere NA; Fletcher EL; Salt TE; Grosche A; Mitchell CH
    Exp Eye Res; 2014 Oct; 127():270-9. PubMed ID: 25151301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ion Channels in the Eye: Involvement in Ocular Pathologies.
    Giblin JP; Comes N; Strauss O; Gasull X
    Adv Protein Chem Struct Biol; 2016; 104():157-231. PubMed ID: 27038375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of dinucleoside polyphosphates on the ocular surface and other eye structures.
    Carracedo G; Crooke A; Guzman-Aranguez A; Pérez de Lara MJ; Martin-Gil A; Pintor J
    Prog Retin Eye Res; 2016 Nov; 55():182-205. PubMed ID: 27421962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focus on molecules: diadenosine tetraphosphate.
    Guzman-Aranguez A; Loma P; Pintor J
    Exp Eye Res; 2011 Feb; 92(2):96-7. PubMed ID: 21163257
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunolocalisation of P2Y receptors in the rat eye.
    Pintor J; Sánchez-Nogueiro J; Irazu M; Mediero A; Peláez T; Peral A
    Purinergic Signal; 2004 Dec; 1(1):83-90. PubMed ID: 18404404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenine nucleotides and dinucleotides as new substances for the treatment of ocular hypertension and glaucoma.
    Pintor J
    Curr Opin Investig Drugs; 2005 Jan; 6(1):76-80. PubMed ID: 15675606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An NGF mimetic, MIM-D3, stimulates conjunctival cell glycoconjugate secretion and demonstrates therapeutic efficacy in a rat model of dry eye.
    Jain P; Li R; Lama T; Saragovi HU; Cumberlidge G; Meerovitch K
    Exp Eye Res; 2011 Oct; 93(4):503-12. PubMed ID: 21726552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four subunits (αβγδ) of the epithelial sodium channel (ENaC) are expressed in the human eye in various locations.
    Krueger B; Schlötzer-Schrehardt U; Haerteis S; Zenkel M; Chankiewitz VE; Amann KU; Kruse FE; Korbmacher C
    Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):596-604. PubMed ID: 22167092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation.
    Coutinho-Silva R; Stahl L; Cheung KK; de Campos NE; de Oliveira Souza C; Ojcius DM; Burnstock G
    Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1024-35. PubMed ID: 15662049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic receptor agonists and antagonists: effects on ocular function.
    Mitchelson F
    Handb Exp Pharmacol; 2012; (208):263-98. PubMed ID: 22222703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Purinergic Trail for Metastases.
    Ferrari D; Malavasi F; Antonioli L
    Trends Pharmacol Sci; 2017 Mar; 38(3):277-290. PubMed ID: 27989503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell culture models of the ocular barriers.
    Hornof M; Toropainen E; Urtti A
    Eur J Pharm Biopharm; 2005 Jul; 60(2):207-25. PubMed ID: 15939234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model.
    Fujihara T; Murakami T; Fujita H; Nakamura M; Nakata K
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):96-100. PubMed ID: 11133853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of IGF-I and -II, IGF binding proteins (IGFBPs) and IGFBP mRNA in ocular fluids and tissues: potential sites of synthesis of IGFBPs in aqueous and vitreous.
    Arnold DR; Moshayedi P; Schoen TJ; Jones BE; Chader GJ; Waldbillig RJ
    Exp Eye Res; 1993 May; 56(5):555-65. PubMed ID: 7684697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connexin43 is required for production of the aqueous humor in the murine eye.
    Calera MR; Topley HL; Liao Y; Duling BR; Paul DL; Goodenough DA
    J Cell Sci; 2006 Nov; 119(Pt 21):4510-9. PubMed ID: 17046998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focus on molecules: purinergic P2Y(2) receptor.
    Guzman-Aranguez A; Pintor J
    Exp Eye Res; 2012 Dec; 105():83-4. PubMed ID: 22564973
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland.
    Lass JH; Walter EI; Burris TE; Grossniklaus HE; Roat MI; Skelnik DL; Needham L; Singer M; Medof ME
    Invest Ophthalmol Vis Sci; 1990 Jun; 31(6):1136-48. PubMed ID: 1693916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.